Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sichuan Baili Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Cancer Centre, Singapore
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sun Yat-sen University
NRG Oncology
NRG Oncology
Fudan University
Hunan Cancer Hospital
Singapore General Hospital
Baylor College of Medicine
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
First Affiliated Hospital of Guangxi Medical University
M.D. Anderson Cancer Center
Guangzhou Concord Cancer Center
Sun Yat-sen University
Guangxi Medical University
Genmab
Emory University
Affiliated Hospital of Guangdong Medical University
Sun Yat-sen University
Chongqing University Cancer Hospital
Emory University
Stanford University
Shanghai Miracogen Inc.
Sun Yat-sen University
Sun Yat-sen University
Baylor College of Medicine
Sun Yat-sen University
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Xinqiao Hospital of Chongqing
Shanghai Miracogen Inc.